Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer.
Hata T, Uemura M, Danno K, Yoshioka S, Matsuda C, Kagawa Y, Shingai T, Suzuki Y, Tei M, Tanida T, Komori T, Okamura S, Ota H, Takemoto H, Ogino T, Miyoshi N, Yamamoto H, Murata K, Doki Y, Eguchi H.
Hata T, et al. Among authors: doki y.
Sci Rep. 2024 Nov 2;14(1):26434. doi: 10.1038/s41598-024-73222-0.
Sci Rep. 2024.
PMID: 39488510
Free PMC article.
Clinical Trial.